Brief

Boehringer Appeals HHS Win In Medicare Drug Price Suit

By Hannah Albarazi · July 29, 2024, 5:25 PM EDT

Boehringer Ingelheim Pharmaceuticals Inc. notified a Connecticut federal court Friday that it will appeal its loss in a lawsuit challenging a new Medicare drug price negotiation program on the grounds that...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Notice of appeal

Case Information

Case Title

Boehringer Ingelheim Pharmaceuticals, Inc. v. United States Department of Health and Human Services et al

Case Number

3:23-cv-01103

Court

Connecticut

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

August 18, 2023

Recent Articles By Hannah

July 09, 2024
With Chevron's End, LGBTQ+ Healthcare Regs Face New Risk
June 18, 2024
High Court Petition Asks Justices: What's A 'Willful' Kickback?
June 04, 2024
Texas Justices Fuel Confusion Over Abortion Ban Exceptions
May 02, 2024
Feds Call Out Gilead's Efforts To Revise HIV Drug IP Judgment
April 05, 2024
Ind. Can't Undo Abortion Law Injunction In Jewish Org's Case
March 29, 2024
Calif. Justices Rule Living Wills Not A Path To Arbitration
March 05, 2024
Gibson Dunn AI Leader On Weathering The AI Policy Blizzard
February 02, 2024
ACLU Atty On How To Protect Civil Liberties In The AI Era
January 01, 2024
These Are The High-Stakes AI Legal Battles To Watch In 2024
December 05, 2023
Texas Sued By Pregnant Woman Seeking Abortion Care